Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 21, 2020 at 10:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,962
    Likes Received:
    3
    via A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investigating whether compounds based on Gilead’s hepatitis C drug Sovaldi could be used against the outbreak.

    article source